Normal Clinical Outcome in Untreated Subjects with Mild Hyperphenylalaninemia
J. Weglage(University of Münster), Erik Harms(University of Münster), Jonas Denecke(Universität Hamburg), Anja Muntau-Heger(Ludwig-Maximilians-Universität München), U. Wendel(Düsseldorf University Hospital), Per Guldberg(University of Southern Denmark), Johannes Zschocke(Innsbruck Medical University), Harald E. Möller(Max Planck Institute for Human Cognitive and Brain Sciences), Michael Pietsch(University of Münster), Georg F. Hoffmann(Heidelberg University), Hans-Georg Koch(University of Freiburg), Reinhold Feldmann(University of Münster), Flemming Güttler(Kennedy Center), Kurt Ullrich(Universität Hamburg)
Cited by 95
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
MRI of the lungs using hyperpolarized noble gases
|Magnetic Resonance in Medicine|2002|396
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
|Nature Biotechnology|2016|347
Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy
|Nature Genetics|2012|279